Proteomic Study Reveals That Proteins Involved in Metabolic and Detoxification Pathways Are Highly Expressed in HER-2/neu-positive Breast Cancer

This publication has 35 references indexed in Scilit:

• Inhibition of fatty acid synthase (FAS) suppressesHER2/neu(erbB-2) oncogene overexpression in cancer cells
  Proceedings of the National Academy of Sciences, 2004
• Cellular responses to ErbB-2 overexpression in human mammary luminal epithelial cells: comparison of mRNA and protein expression
  British Journal of Cancer, 2004
• cDNA microarray analysis of genes associated with ERBB2 (HER2/neu) overexpression in human mammary luminal epithelial cells
  Oncogene, 2003
• Evaluation of HER-2/neu oncogene status in breast tumors on tissue microarrays
  Human Pathology, 2003
• The deaf and the dumb: the biology of ErbB-2 and ErbB-3
  Experimental Cell Research, 2003
• Differential Gene Expression Patterns in HER2/neu-Positive and -Negative Breast Cancer Cell Lines and Tissues
  The American Journal of Pathology, 2002
• HER2 (neu) Signaling Increases the Rate of Hypoxia-Inducible Factor 1α (HIF-1α) Synthesis: Novel Mechanism for HIF-1-Mediated Vascular Endothelial Growth Factor Expression
  Molecular and Cellular Biology, 2001
• Untangling the ErbB signalling network
  Nature Reviews Molecular Cell Biology, 2001
• Heregulin Regulates Cytoskeletal Reorganization and Cell Migration through the p21-activated Kinase-1 via Phosphatidylinositol-3 Kinase
  Journal of Biological Chemistry, 1998
• The role of ErbB-2 tyrosine kinase receptor in cellular intrinsic chemoresistance: mechanisms and implications
  Biochemistry and Cell Biology, 1997